BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3987836)

  • 1. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
    OKunewick JP; Buffo MJ; Kociban DL
    Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
    Soderberg LS; Flick JT; Barnett JB
    Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells.
    Huybrechts M; Symann M; Trouet A
    Cancer Res; 1979 Sep; 39(9):3738-43. PubMed ID: 476697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for measuring suppression of hematopoiesis.
    Chervenick PA
    Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE; Hannon EC; Vigneulle R; Hellman S
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors.
    Kovacs CJ; Johnke RM; Evans MJ; Emma DA; Hooker JL
    Exp Hematol; 1986 Mar; 14(3):165-72. PubMed ID: 3948928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene.
    Seidel HJ; Barthel E; Zinser D
    Exp Hematol; 1989 Mar; 17(3):300-3. PubMed ID: 2917624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of benzene inhalation on murine hematopoietic precursor cells (CFU-e, BFU-e and CFU-gm).
    Hilderbrand RL; Murphy MJ
    Int J Cell Cloning; 1983 Sep; 1(4):240-53. PubMed ID: 6668429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged expansion of marrow progenitor compartments following doxorubicin (ADR) on subsequent radiation tolerance.
    Kovacs CJ; Johnke RM; Emma DA; Scarantino CW
    Exp Hematol; 1985; 13 Suppl 16():89-94. PubMed ID: 3987840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
    Wu DD; Nayar R; Keating A
    Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of leukemic and normal stem cells in leukemic RFM mice.
    Husseini S; Fried W; Knospe WH; Trobaugh FE
    Cancer Res; 1976 May; 36(5):1784-9. PubMed ID: 1268835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.
    Loeffler M; Bungart B; Goris H; Schmitz S; Nijhof W
    Exp Hematol; 1989 Oct; 17(9):962-7. PubMed ID: 2776856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
    Laerum OD; Paukovits WR
    Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium and hematopoietic toxicity. I. Recovery in vivo of murine hematopoietic stem cells (CFU-S and CFU-Mix) after single-dose administration of cyclophosphamide.
    Gallicchio VS
    Exp Hematol; 1986 Jun; 14(5):395-400. PubMed ID: 3709709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiserum to mouse hematopoietic pluripotent stem cells (CFU-S): further investigation of its functional properties.
    Kuznetsky RD; Trobaugh FE; Adler SS
    Exp Hematol; 1979 Aug; 7(7):369-76. PubMed ID: 488193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium and hematopoietic toxicity. II. Acceleration in vivo of murine hematopoietic progenitor cells (CFU-gm and CFU-meg) following treatment with vinblastine sulfate.
    Gallicchio VS
    Int J Cell Cloning; 1987 Mar; 5(2):122-33. PubMed ID: 3572050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of high doses of cytosine arabinoside on pluripotent stem cells (CFU-S).
    Guigon M; Izumi-Hisha H; Mary JY
    Exp Hematol; 1989 Feb; 17(2):203-7. PubMed ID: 2912743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.